The FDA wrote published its draft guidance on the development of bispecific antibodies in April. And boy, the industry wasn’t happy about it!
Follow me on:
Youtube: <a href="https://gate.sc/?url=http%3A%2F%2Fyoutube.com%2Fhaveyoueverwondered&token=ea825b-1-1566393724457" rel="nofollow" target="_blank" title="http://youtube.com/haveyoueverwondered">youtube.com/haveyoueverwondered</a> 
LinkedIn: <a href="https://gate.sc/?url=http%3A%2F%2Fwww.linkedin.com%2Fin%2Fmginai%2F&token=6f8005-1-1566393724457" rel="nofollow" target="_blank" title="http://www.linkedin.com/in/mginai/">www.linkedin.com/in/mginai/</a> 
Facebook: <a href="https://gate.sc/?url=http%3A%2F%2Ffacebook.com%2Fhyewscience&token=73d379-1-1566393724457" rel="nofollow" target="_blank" title="http://facebook.com/hyewscience">facebook.com/hyewscience</a> 
Twitter: <a href="https://gate.sc/?url=http%3A%2F%2Ftwitter.com%2Fhyewscience&token=c72582-1-1566393724457" rel="nofollow" target="_blank" title="http://twitter.com/hyewscience">twitter.com/hyewscience</a> 
Instagram: <a href="https://gate.sc/?url=http%3A%2F%2Finstagram.com%2Fhyewscience&token=effd8-1-1566393724457" rel="nofollow" target="_blank" title="http://instagram.com/hyewscience">instagram.com/hyewscience</a>
Content by Maaria Ginai (C) 2019

The FDA wrote published its draft guidance on the development of bispecific antibodies in April. And boy, the industry wasn’t happy about it! Follow me on: Youtube: youtube.com/haveyoueverwondered LinkedIn: www.linkedin.com/in/mginai/ Facebook: facebook.com/hyewscience Twitter: twitter.com/hyewscience Instagram: instagram.com/hyewscience Content by Maaria Ginai (C) 2019

The FDA wrote published its draft guidance on the development of bispecific antibodies in April. And boy, the industry wasn’t happy about it!
Follow me on:
Youtube: <a href="https://gate.sc/?url=http%3A%2F%2Fyoutube.com%2Fhaveyoueverwondered&amp;token=ea825b-1-1566393724457" title="http://youtube.com/haveyoueverwondered" rel="noopener noreferrer">youtube.com/haveyoueverwondered</a> 
LinkedIn: <a href="https://gate.sc/?url=http%3A%2F%2Fwww.linkedin.com%2Fin%2Fmginai%2F&amp;token=6f8005-1-1566393724457" title="http://www.linkedin.com/in/mginai/" rel="noopener noreferrer">www.linkedin.com/in/mginai/</a> 
Facebook: <a href="https://gate.sc/?url=http%3A%2F%2Ffacebook.com%2Fhyewscience&amp;token=73d379-1-1566393724457" title="http://facebook.com/hyewscience" rel="noopener noreferrer">facebook.com/hyewscience</a> 
Twitter: <a href="https://gate.sc/?url=http%3A%2F%2Ftwitter.com%2Fhyewscience&amp;token=c72582-1-1566393724457" title="http://twitter.com/hyewscience" rel="noopener noreferrer">twitter.com/hyewscience</a> 
Instagram: <a href="https://gate.sc/?url=http%3A%2F%2Finstagram.com%2Fhyewscience&amp;token=effd8-1-1566393724457" title="http://instagram.com/hyewscience" rel="noopener noreferrer">instagram.com/hyewscience</a>
Content by Maaria Ginai (C) 2019

Backlash around the FDA's guidance on Bispecific Antibodies

The most talked about stories in biotech? Here's what I think about them.

Share Backlash around the FDA's guidance on Bispecific Antibodies

Sign up to save your podcasts

Backlash around the FDA's guidance on Bispecific Antibodies

Backlash around the FDA's guidance on Bispecific Antibodies